While “Speed of Delivery” Tops the List of Medical Affairs Challenges, Active Use of Automation Is Still in the Early Stages

Jul 25, 2019

On June 18th, 2019, ArisGlobal presented the webinar Effective Automated Content Management Strategies for Today’s Successful Medical Information Managers.” When polled, 40%  of attendees rated “speed of delivering information” as their top challenge, yet only 13% have adopted automated component authoring to help remedy the situation. That and other interesting insights are shared in this first of a two-part blog series.

Nearly two years ago, ArisGlobal published a “Mobility and Medical Affairs” blog that kicked off with a quote from Bain & Company’s June 2017 industry brief: “The most competitive pharma companies in the coming decade will be masters of data and digital technologies.”

That quote remains just as true today as it did in 2017. Today’s pharmaceutical and medical device consumer/ patient is digitally savvy and has higher expectations for quick responses to their queries. Physicians are now becoming less reliant on sales representatives and are turning to more scientific sources of information. These and other factors are placing a lot of pressure on medical information (MI) teams to provide accurate and timely responses at greater speed.

What is your top percieved challenge when it comes to managing your medical affairs content?

  • OTHERS 7% 7%

Given this reality, increasing volumes in calls by patients, healthcare professionals (HCPs) and other stakeholders are on the rise and likely to continue as product launches, new communication channels, and other factors of our modern age continue to unfold. While standard response documents (SRDs) are commonly used to help create consistent responses, they require authoring, review, approval, distribution, maintenance, version control, and often need to be translated into local languages, all of which exponentially multiplies the effort involved.

Automated content management can help streamline, enable workflow-driven capabilities, component authoring, and more throughout the creation, management, and distribution of SRDs – all areas where ArisGlobal has been working closely with top customers to advance. Yet, when webinar attendees were asked to what extent they have already adopted component authoring for SRDs, nearly 13% were fully implemented while nearly 19% were in progress. At just under 69%, most attendees are still holding back on this effort, but in another year’s time these percentages will most certainly increase as MI departments become more knowledgeable for how automation can ease the complexity of medical information processes.

Have you adopted component authoring for standard response documents?

  • NO 68.8% 68.8%
  • YES, FULLY IMPLEMENTED 12.6% 12.6%

In our concluding blog, to be published next week, we will share what we think are the necessary functionality today’s content management system needs to provide, especially with the move to self-service. If waiting until then is not ideal, view the on-demand webinar and read our article, “The Role of Artificial Intelligence Within Pharmacovigilance and Medical Information.”

Request a Demo


About ArisGlobal

ArisGlobal is transforming the way today’s most successful Life Sciences companies develop breakthroughs and bring new products to market. Our end-to-end drug development technology platform, LifeSphere®, integrates our proprietary Nava® cognitive computing engine to automate all core functions of the drug development lifecycle. Designed with deep expertise and a long-term perspective that spans more than 30 years, LifeSphere® is a unified platform that boosts efficiency, ensures compliance, delivers actionable insights, and lowers total cost of ownership through multi-tenant SaaS architecture.

Headquartered in the United States, ArisGlobal has regional offices in Europe, India, Japan and China. For more updates, follow ArisGlobal on LinkedIn and Twitter.

Additional Information

Connect with ArisGlobal on LinkedIn: linkedin.com/company/aris-global
Follow @Aris_Global on Twitter: twitter.com/aris_global


Erika Thomas
+305-726-6601 | ethomas@arisglobal.com